Journal of Critical Care
Volume 25, Issue 1 , Pages 23-29 , March 2010

Atrial and brain natriuretic peptide concentrations and the response to inhaled nitric oxide in patients with acute respiratory distress syndrome

  • Miriam M. Treggiari, MD, PhD, MPH

      Affiliations

    • Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Harborview Medical Center, PO Box 359724, Seattle, WA 98104, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 206 731 5039; fax: +1 206 731 8090.
    • ,
  • Karim Bendjelid, MD, PhD

      Affiliations

    • Division of Intensive Care, Department of Anesthesiology, Pharmacology and Intensive Care, Geneva University Hospitals, Switzerland
    • ,
  • N. David Yanez, PhD

      Affiliations

    • Department of Biostatistics, University of Washington, Seattle, WA, USA
    • ,
  • Claudia-Paula Heidegger, MD

      Affiliations

    • Division of Intensive Care, Department of Anesthesiology, Pharmacology and Intensive Care, Geneva University Hospitals, Switzerland
    • ,
  • Peter M. Suter, MD

      Affiliations

    • University of Geneva, Geneva, Switzerland
    • ,
  • Jacques-André Romand, MD

      Affiliations

    • Division of Intensive Care, Department of Anesthesiology, Pharmacology and Intensive Care, Geneva University Hospitals, Switzerland

References 

  1. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818–824
  2. Rossaint R, Falke KJ, Lopez F, et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993;328:399–405
  3. Dellinger RP, Zimmerman JL, Taylor RW, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med. 1998;26:15–23
  4. Michael JR, Barton RG, Saffle JR, et al. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med. 1998;157:1372–1380
  5. Troncy E, Collet JP, Shapiro S, et al. Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study. Am J Respir Crit Care Med. 1998;157:1483–1488
  6. Lundin S, Mang H, Smithies M, et al. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med. 1999;25:911–919
  7. Taylor RW, Zimmerman JL, Dellinger RP, et al. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. Jama. 2004;291:1603–1609
  8. Rossaint R, Pison U, Gerlach H, et al. Inhaled nitric oxide: its effects on pulmonary circulation and airway smooth muscle cells. Eur Heart J. 1993;14(Suppl I):133–140
  9. Treggiari-Venzi M, Ricou B, Romand JA, et al. The response to repeated nitric oxide inhalation is inconsistent in patients with acute respiratory distress syndrome. Anesthesiology. 1998;88:634–641
  10. Manktelow C, Bigatello LM, Hess D, et al. Physiologic determinants of the response to inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology. 1997;87:297–307
  11. McIntyre RC, Moore FA, Moore EE, et al. Inhaled nitric oxide variably improves oxygenation and pulmonary hypertension in patients with acute respiratory distress syndrome. J Trauma. 1995;39:418–425
  12. Gust R, McCarthy TJ, Kozlowski J, et al. Response to inhaled nitric oxide in acute lung injury depends on distribution of pulmonary blood flow prior to its administration. Am J Respir Crit Care Med. 1999;159:563–570
  13. Lukaszewicz AC, Mebazaa A, Callebert J, et al. Lack of alteration of endogenous nitric oxide pathway during prolonged nitric oxide inhalation in intensive care unit patients. Crit Care Med. 2005;33:1008–1014
  14. Langleben D, DeMarchie M, Laporta D, et al. Endothelin-1 in acute lung injury and the adult respiratory distress syndrome. Am Rev Respir Dis. 1993;148:1646–1650
  15. Leskinen H, Vuolteenaho O, Leppaluoto J, et al. Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-l-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release. Endocrinology. 1995;136:1241–1249
  16. Amin J, Carretero OA, Ito S. Mechanisms of action of atrial natriuretic factor and C-type natriuretic peptide. Hypertension. 1996;27:684–687
  17. Rosenzweig A, Seidman CE. Atrial natriuretic factor and related peptide hormones. Ann Rev Biochem. 1991;60:229–255
  18. Takahashi M, Takeda S, Kurokawa S, et al. Cyclic GMP production by ANP, BNP, and NO during worsening and improvement of chronic heart failure. Jpn Heart J. 2003;44:713–724
  19. Maeder M, Ammann P, Rickli H, et al. Elevation of B-type natriuretic peptide levels in acute respiratory distress syndrome. Swiss Med Wkly. 2003;133:515–518
  20. Germann P, Braschi A, Della Rocca G, et al. Inhaled nitric oxide therapy in adults: European expert recommendations. Intensive Care Med. 2005;31:1029–1041
  21. Adnot S, Andrivet P, Chabrier PE, et al. Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion. J Clin Invest. 1989;83:986–993
  22. Andrivet P, Chabrier PE, Defouilloy C, et al. Intravenously administered atrial natriuretic factor in patients with COPD. Effects on ventilation-perfusion relationships and pulmonary hemodynamics. Chest. 1994;106:118–124
  23. Mitaka C, Hirata Y, Nagura T, et al. Increased plasma concentrations of brain natriuretic peptide in patients with acute lung injury. J Crit Care. 1997;12:66–71
  24. Nagaya N, Nishikimi T, Okano Y, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol. 1998;31:202–208
  25. Vieillard-Baron A, Charron C, Caille V, et al. Prone positioning unloads the right ventricle in severe ARDS. Chest. 2007;132:1440–1446
  26. Bendjelid K. Impact of pulmonary artery occlusion pressure value on the definition of acute respiratory distress syndrome. Intensive Care Med. 2003;29:499;[author reply 500]
  27. Vieillard-Baron A, Jardin F. Why protect the right ventricle in patients with acute respiratory distress syndrome?. Curr Opin Crit Care. 2003;9:15–21
  28. Ghofrani HA, Wiedemann R, Rose F, et al. Lung cGMP release subsequent to NO inhalation in pulmonary hypertension: responders versus nonresponders. Eur Respir J. 2002;19:664–671
  29. Zwissler B, Kemming G, Merkel M, et al. Response to inhaled nitric oxide (NO) is not associated with changes of plasma cGMP levels in patients with acute lung injury. Eur J Med Res. 1999;4:463–467
  30. Kucher N, Printzen G, Doernhoefer T, et al. Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism. Circulation. 2003;107:1576–1578
  31. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345:1014–1021
  32. Castillo JR, Zagler A, Carrillo-Jimenez R, et al. Brain natriuretic peptide: a potential marker for mortality in septic shock. Int J Infect Dis. 2004;8:271–274
  33. Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J. 2001;141:367–374

☆ Research support: Financial support was provided by Departmental funds.

PII: S0883-9441(08)00237-2

doi: 10.1016/j.jcrc.2008.10.014

Journal of Critical Care
Volume 25, Issue 1 , Pages 23-29 , March 2010

Article Tools

* Image Usage & Resolution